Functional characterization of BRCC3 mutations in acute myeloid leukemia with t(8;21)(q22;q22.1)
Tatjana Meyer(University Hospital Ulm), Jan Krönke(Universitätsmedizin Greifswald)
Cited by 28
Related Papers
Monitoring of Minimal Residual Disease in <i>NPM1</i> -Mutated Acute Myeloid Leukemia: A Study From the German-Austrian Acute Myeloid Leukemia Study Group
|Journal of Clinical Oncology|2011|393
Proteomic profiling reveals CDK6 upregulation as a targetable resistance mechanism for lenalidomide in multiple myeloma
|Nature Communications|2022|67
Teclistamab in relapsed systemic sclerosis after autologous haematopoietic stem cell transplantation
|Annals of the Rheumatic Diseases|2025|15